Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent
- PMID: 19668473
- PMCID: PMC2701135
Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent
Abstract
Thymosin beta 4 (Tbeta(4)) is a low molecular weight protein present in all cells except erythrocytes. Although Tbeta(4) is the major monomeric actin-sequestering peptide in cells and can depolymerize F-actin, evidence is mounting to support the idea that it has multiple, seemingly diverse, cellular functions. In cornea, as in other tissues, Tbeta(4) promotes cell migration and wound healing, has anti-inflammatory properties, and suppresses apoptosis. In this review we discuss the current state of knowledge regarding the effects of Tbeta(4) in maintaining the healthy, functional cornea. The clinical implications of the use of Tbeta(4) as a wound healing and anti-inflammatory agent are discussed.
Keywords: apoptosis; cell migration; cornea; inflammation; thymosin beta 4; wound healing.
Figures
References
-
- Agrawal VB, Tsai RJ. Corneal epithelial wound healing. Indian J Ophthalmol. 2003;51:5–15. - PubMed
-
- Badamchian M, Fagarasan MO, Danner RL, et al. Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock. Int Immunopharmacol. 2003;3:1225–33. - PubMed
-
- Bock-Marquette A, Saxena M, White MD, et al. Thymosin beta 4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004;432:466–72. - PubMed
-
- Choi SY, Kim DK, Eun B, et al. Anti-apoptotic function of thymosin-beta in developing chick spinal motoneurons. Biochem Biophys Res Commun. 2006;346:872–8. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources